Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11,500.00
Bid: 11,400.00
Ask: 11,600.00
Change: -100.00 (-0.88%)
Spread: 200.00 (1.754%)
Open: 11,250.00
High: 11,500.00
Low: 11,200.00
Prev. Close: 11,300.00
JDG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Term Loan and Acquisition Facility

23 Dec 2014 14:10

RNS Number : 6123A
Judges Scientific PLC
23 December 2014
 

 

 

 

Judges Scientific plc

 

23 December 2014

 

 

Judges Scientific plc

New Term Loan and Acquisition Facility

 

Judges Scientific plc ("the Group") is pleased to announce that it has agreed a new acquisition facility with its bank, Lloyds Bank plc (the "Bank").

 

All existing term loans, with the exception of the loans granted to the Company's 51% owned subsidiary, Bordeaux Acquisition Limited, have been consolidated into one £11.3 million term loan repayable in 20 quarterly instalments (the "Term Loan"). In addition, the Group has entered into a new £10.0 million revolving acquisition facility (the "Acquisition Facility"). The Acquisition Facility has been put in place to simplify the acquisition funding process both for "permitted acquisitions", which fall within set criteria, and for larger transactions where the consent process has been streamlined. The 'revolving' characteristic also serves to streamline the process in respect of any increase in the Acquisition Facility that may be agreed with the Bank in the future.

 

Taken together, the introduction of the Acquisition Facility alongside the Term Loan will enable the Group to operate its facilities in a more cost effective manner through the optimum application of cash generated from the business. In particular, it will eliminate the need to maintain large unproductive cash balances. The immediate impact on earnings per share is not expected to be material. However, the new pricing structure will ensure that the interest margin for both facilities, which will fluctuate by reference to gearing, will create opportunities for cost benefits.

 

Ralph Cohen, the Company's Finance Director, commented: "The Group has reached a size and scale which warrants a more appropriate banking structure. This will facilitate M&A transactions and is testament to Lloyds Bank's long-standing support of the Group's growth strategy".

 

 

 

For further information please contact:

Judges Scientific plc

David Cicurel, CEO

Tel: 01342 323 600

 

Shore Capital (Nominated Adviser & Broker)

Pascal Keane

Edward Mansfield

Tel: 020 7408 4090

 

Cardew Group (Financial Public Relations)

Melvyn Marckus

Tel: 0207 930 0777 or 07775 896 491

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCPGGCUPUPCGCW
Date   Source Headline
28th Mar 200612:31 pmRNSDirector/PDMR Shareholding
21st Mar 20067:01 amRNSFinal Results
21st Mar 20067:00 amRNSPreliminary Results
16th Mar 20062:25 pmRNSNotice of Preliminary Results
28th Feb 200611:42 amRNSAdditional Listing
23rd Feb 20066:15 pmRNSDirector/PDMR Shareholding
22nd Feb 20067:01 amRNSAcquisition
24th Nov 20057:01 amRNSClarification of Holding
16th Nov 200510:55 amRNSHolding(s) in Company
24th Oct 200512:03 pmRNSAppointment of Director
27th Sep 20057:01 amRNSDirector/PDMR Shareholding
15th Sep 20057:01 amRNSInterim Results
5th Sep 20051:25 pmRNSAcquisition
17th Jun 20055:22 pmRNSHolding(s) in Company
27th May 20057:00 amRNSHolding(s) in Company
23rd May 20055:20 pmRNSResult of EGM
6th May 200510:43 amRNSSchedule 1 - Judges Capital
29th Apr 20057:02 amRNSAcquisition and Placing
29th Apr 20057:02 amRNSFinal Results and Acquisition
14th Jan 20058:38 amRNSHolding(s) in Company
10th Jan 20059:30 amRNSSale of investment
10th Jan 20059:20 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.